Cabaletta Bio

Clinical-stage biotechnology company focused on T cell therapies

Based in PA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $50K in lobbying spend across 5 quarterly filings, Cabaletta Bio is an active lobbying client. Their lobbying covers 1 issue area.

$50K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2025$50K

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

Hogan Lovells US LLP

Lobbyists

Adam FridmanCybil Roehrenbeck

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

  • •Specific lobbying issues: Cell and gene therapy innovation and access
  • •Cell and gene therapy innovation and access

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Select Medical Holdings Corporation
$22.2M total spend
Highmark INC
$8.8M total spend
Spark Therapeutics, INC.
$6.2M total spend
Trustees of the University of Pennsylvania
$4.7M total spend
Select Medical Corporation
$4.5M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.